JP2005517669A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005517669A5 JP2005517669A5 JP2003556003A JP2003556003A JP2005517669A5 JP 2005517669 A5 JP2005517669 A5 JP 2005517669A5 JP 2003556003 A JP2003556003 A JP 2003556003A JP 2003556003 A JP2003556003 A JP 2003556003A JP 2005517669 A5 JP2005517669 A5 JP 2005517669A5
- Authority
- JP
- Japan
- Prior art keywords
- ssri
- manufacture
- ssris
- therapeutically effective
- serotonin reuptake
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 claims 18
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 claims 15
- 230000037431 insertion Effects 0.000 claims 5
- 238000003780 insertion Methods 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 4
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 claims 2
- 229960002464 fluoxetine Drugs 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 210000001215 vagina Anatomy 0.000 claims 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 claims 1
- WSEQXVZVJXJVFP-HXUWFJFHSA-N (R)-citalopram Chemical compound C1([C@@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-HXUWFJFHSA-N 0.000 claims 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 claims 1
- 229960001653 citalopram Drugs 0.000 claims 1
- 229960004038 fluvoxamine Drugs 0.000 claims 1
- CJOFXWAVKWHTFT-XSFVSMFZSA-N fluvoxamine Chemical compound COCCCC\C(=N/OCCN)C1=CC=C(C(F)(F)F)C=C1 CJOFXWAVKWHTFT-XSFVSMFZSA-N 0.000 claims 1
- 229960002296 paroxetine Drugs 0.000 claims 1
- 229960002073 sertraline Drugs 0.000 claims 1
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34325401P | 2001-12-21 | 2001-12-21 | |
| US10/095,558 US7005138B2 (en) | 2001-12-21 | 2002-03-12 | Method of systematically delivering SSRIs |
| PCT/US2002/040808 WO2003055424A1 (en) | 2001-12-21 | 2002-12-20 | METHOD OF SYSTEMICALLY DELIVERING SSRIs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005517669A JP2005517669A (ja) | 2005-06-16 |
| JP2005517669A5 true JP2005517669A5 (https=) | 2005-12-22 |
Family
ID=26790345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003556003A Pending JP2005517669A (ja) | 2001-12-21 | 2002-12-20 | Ｓｓｒｉ全身送達方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7005138B2 (https=) |
| EP (1) | EP1465563A4 (https=) |
| JP (1) | JP2005517669A (https=) |
| AU (1) | AU2002357352B2 (https=) |
| CA (1) | CA2471039A1 (https=) |
| MX (1) | MXPA04006198A (https=) |
| WO (1) | WO2003055424A1 (https=) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040043071A1 (en) * | 2002-06-21 | 2004-03-04 | Pauletti Giovanni M. | Intravaginal mucosal or transmucosal delivery of antimigraine and antinausea drugs |
| MX2013000002A (es) * | 2001-07-27 | 2013-04-29 | Teva Womens Health Inc | Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva. |
| US7544681B2 (en) | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
| US20050101666A1 (en) * | 2003-11-07 | 2005-05-12 | H. Lundbeck A/S | Method of treating premenstrual dysphoric disorder with escitalopram |
| IL159273A0 (en) * | 2003-12-09 | 2004-06-01 | Transpharma Medical Ltd | Transdermal delivery system for sustained release of polypeptides |
| JP5265359B2 (ja) | 2005-08-11 | 2013-08-14 | マサチューセッツ インスティテュート オブ テクノロジー | 膀胱内薬物送達デバイスおよび方法 |
| WO2008010223A2 (en) * | 2006-07-17 | 2008-01-24 | Ramot At Tel Aviv University Ltd. | Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders |
| US20090209622A1 (en) * | 2006-11-21 | 2009-08-20 | Smoller Jordan W | Diagnosis of anxiety disorders |
| WO2008112641A2 (en) * | 2007-03-09 | 2008-09-18 | New York University | Methods and compositions for treating thalamocortical dysrhythmia |
| FI7960U1 (fi) | 2007-04-27 | 2008-07-28 | Bayer Schering Pharma Oy | Implantoitavan annostelusysteemin membraanikuori |
| CA2692187A1 (en) * | 2007-06-29 | 2009-01-08 | Carmanah Technologies Corp. | Intelligent area lighting system |
| US9586035B2 (en) | 2007-12-11 | 2017-03-07 | Massachusetts Institute Of Technology | Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens |
| US9138430B2 (en) * | 2007-12-27 | 2015-09-22 | Mylan Specialty L.P. | Formulation and method for the release of paroxetine in the large intestine |
| US8207369B2 (en) | 2008-02-11 | 2012-06-26 | Ramot At Tel-Aviv University Ltd. | Conjugates for treating neurodegenerative diseases and disorders |
| EA201170297A1 (ru) | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей |
| US20100040671A1 (en) * | 2008-08-12 | 2010-02-18 | Ahmed Salah U | Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof |
| FI121000B (fi) * | 2008-11-19 | 2010-06-15 | Bayer Schering Pharma Oy | Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi |
| CN102470237A (zh) | 2009-06-26 | 2012-05-23 | 塔里斯生物医药公司 | 用于可植入药物递送装置的固体药物片剂 |
| US9017312B2 (en) * | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| CA2789654A1 (en) | 2010-02-24 | 2011-09-01 | Ramot At Tel-Aviv University Ltd. | Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same |
| EP2585011A4 (en) * | 2010-06-22 | 2014-10-15 | Teva Womens Health Inc | INTRAVAGINAL DEVICES HAVING CHOLINOLYTIC AGENTS AND METHODS OF MAKING SAME |
| WO2012038963A1 (en) | 2010-09-22 | 2012-03-29 | Ramot At Tel-Aviv University Ltd. | An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same |
| US9114111B2 (en) | 2011-01-10 | 2015-08-25 | Allergan, Inc. | Methods for sustained treatment of bladder pain and irritative voiding |
| AU2012211960B2 (en) | 2011-02-04 | 2016-12-01 | Taris Biomedical Llc | Implantable device for controlled release of low solubility drug |
| GB201115592D0 (en) * | 2011-09-09 | 2011-10-26 | Vivosens Medical Gmbh | Flexible ring pessary |
| US20150196533A1 (en) * | 2012-07-02 | 2015-07-16 | The General Hospital Corporation | Method for concurrent treatment of pain and depression |
| USD703319S1 (en) * | 2012-09-07 | 2014-04-22 | Vivosensmedical Gmbh | Ring pessary |
| PT2968880T (pt) | 2013-03-15 | 2025-07-07 | Taris Biomedical Llc | Dispositivos de aplicação de fármaco com componente permeável a fármaco |
| CN113413393B (zh) | 2013-08-19 | 2025-03-04 | 塔里斯生物医药公司 | 多单元药物递送装置和方法 |
| CN104546267B (zh) * | 2015-01-13 | 2017-01-04 | 安徽农业大学 | 一种犬用宫外节育装置及其节育方法 |
| FI3250183T3 (fi) * | 2015-01-30 | 2024-08-06 | Ligalli B V | Vaginaalinen lääkkeenantolaite |
| KR102658706B1 (ko) | 2015-04-23 | 2024-04-17 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 성분을 구비한 약물 전달 장치 및 방법 |
| CA201546S (en) | 2019-03-08 | 2022-01-28 | Rite Hite Holding Corp | Mounting device for fan and light |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3711602A (en) * | 1970-10-30 | 1973-01-16 | Crown Zellerbach Corp | Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso |
| IL48277A (en) * | 1974-10-18 | 1978-03-10 | Schering Ag | Vaginal ring |
| US4442113A (en) * | 1981-05-07 | 1984-04-10 | A/S Ferrosan | Long-term weight reduction of obese patients using femoxetine |
| JPH0984855A (ja) * | 1995-09-25 | 1997-03-31 | Kyoto Yakuhin Kogyo Kk | 直腸または膣への薬物投与用のエアゾール製剤 |
| GB9522403D0 (en) * | 1995-11-01 | 1996-01-03 | Hoechst Roussel Ltd | Intravaginal drug delivery device |
| ES2227707T3 (es) * | 1996-07-15 | 2005-04-01 | Alza Corporation | Nuevas formulaciones para la administracion transdermica de acetato de fluoxetina y de maleato de fluoxetina. |
| WO1998011888A1 (en) * | 1996-09-19 | 1998-03-26 | American Home Products Corporation | Method of treating urinary incontinence |
| US6039968A (en) * | 1997-06-24 | 2000-03-21 | Hoechst Marion Roussel | Intravaginal drug delivery device |
| CA2290966C (en) * | 1997-07-01 | 2005-12-20 | Pfizer Inc. | Sertraline salts and sustained-release dosage forms of sertraline |
| US6248358B1 (en) * | 1998-08-25 | 2001-06-19 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets and methods of making and using the same |
| US6228864B1 (en) * | 1997-10-28 | 2001-05-08 | Vivus, Inc. | Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation |
| EP1073432B1 (en) * | 1998-04-14 | 2007-08-15 | The General Hospital Corporation | Use of d-serine or d-alanine for treating schizophrenia |
| WO1999059593A1 (en) * | 1998-05-21 | 1999-11-25 | Eli Lilly And Company | Combination therapy for treatment of depression |
| US6331571B1 (en) * | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
| US6342533B1 (en) * | 1998-12-01 | 2002-01-29 | Sepracor, Inc. | Derivatives of (−)-venlafaxine and methods of preparing and using the same |
| US6239162B1 (en) * | 1999-05-17 | 2001-05-29 | St. Elizabeth's Medical Center | Method for treating depression |
| NZ516083A (en) * | 1999-05-27 | 2003-08-29 | Acusphere Inc | Porous drug matrices and methods of manufacture thereof |
| US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| US6264973B1 (en) * | 1999-08-26 | 2001-07-24 | Fei Enterprises, Ltd. | Apparatus and method for anesthetizing the cervical region of a female |
| US20020192302A1 (en) * | 1999-12-16 | 2002-12-19 | Tsung-Min Hsu | Transdermal and topical administration of antidepressant drugs using basic enhancers |
| GB0009914D0 (en) * | 2000-04-20 | 2000-06-07 | Metris Therapeutics Limited | Device |
| AU2002313517B2 (en) * | 2001-08-31 | 2007-09-06 | Bayer Schering Pharma Oy | Drug delivery system |
| CN100581550C (zh) * | 2001-12-05 | 2010-01-20 | 杜拉美德药物有限公司 | 预防怀孕和减少经期前症状的口服避孕药 |
-
2002
- 2002-03-12 US US10/095,558 patent/US7005138B2/en not_active Expired - Fee Related
- 2002-12-20 WO PCT/US2002/040808 patent/WO2003055424A1/en not_active Ceased
- 2002-12-20 MX MXPA04006198A patent/MXPA04006198A/es active IP Right Grant
- 2002-12-20 JP JP2003556003A patent/JP2005517669A/ja active Pending
- 2002-12-20 EP EP02805965A patent/EP1465563A4/en not_active Withdrawn
- 2002-12-20 CA CA002471039A patent/CA2471039A1/en not_active Abandoned
- 2002-12-20 AU AU2002357352A patent/AU2002357352B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005517669A5 (https=) | ||
| ES2530719T3 (es) | Formulaciones de oxicodona para ser administradas una vez al día | |
| Boddupalli et al. | Mucoadhesive drug delivery system: An overview | |
| JP2005512995A5 (https=) | ||
| ZA959469B (en) | Pharmaceutical composition | |
| ATE330589T1 (de) | Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege | |
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| HRP20160189T1 (hr) | Liječenje crohnove bolesti lakvinimodom | |
| JP2004505046A5 (https=) | ||
| JP2009535397A (ja) | 経粘膜的組成物 | |
| JP2009522370A5 (https=) | ||
| EP2364144A4 (en) | PHARMACEUTICAL FORM FOR ADMINISTRATION THROUGH THE MOUTH | |
| JP2013544850A5 (https=) | ||
| EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
| JP2005515966A5 (https=) | ||
| HRP20140657T1 (hr) | Laminin-1 za primjenu radi pojaäśanja regeneracije mišiä†a nakon ozljede ili za bolje zacjeljivanje rana ako se daje sistemski | |
| HRP20121033T1 (hr) | Praškasta formulacija za valganciklovir | |
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| JP2008542299A5 (https=) | ||
| Chaudhari et al. | Mucoadhesive buccal drug delivery system: A Review. | |
| JP2002521490A5 (https=) | ||
| NO982904D0 (no) | Oral farmas°ytisk sammensetning inneholdende 5-ASA, med modifisert frigj°ring, og fremgangsmÕte for behandling av tarmsykdommer | |
| JP2007530620A5 (https=) | ||
| JP2003520208A5 (https=) | ||
| JP2002509154A5 (https=) |